Chelator
Showing 151 - 161 of 161
Non-Hodgkin's Lymphoma Trial in Beer Sheva (90Yttrium Ibritumomab Tiuxetan (Zevalin))
Unknown status
- Non-Hodgkin's Lymphoma
- 90Yttrium Ibritumomab Tiuxetan (Zevalin)
-
Beer Sheva, IsraelSoroka Universuty Medical Center
Jul 11, 2012
Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,
Unknown status
- Beta-thalassemia Major
- +2 more
- DFP (ferriprox) and deferasirox (ICL 670)
- DFP, DFO
-
Cairo, EgyptPediatric Hematology clinic, Ain Shams University
Feb 3, 2012
Sickle Cell Anemia, Sickle Cell Thalassemia, Iron Overload Trial in Afula (Cardiac and Liver T2* MRI)
Completed
- Sickle Cell Anemia
- +3 more
- Cardiac and Liver T2* MRI
-
Afula, IsraelPediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical C
Aug 25, 2011
Contrast-Induced Acute Kidney Injury Trial in United States (CRMD-001-Deferiprone, Placebo)
Completed
- Contrast-Induced Acute Kidney Injury
- CRMD-001-Deferiprone
- Placebo
-
Indianapolis, Indiana
- +7 more
Jun 23, 2011
Toxicity Trial in Phoenix (transdermal DMPS)
Completed
- Toxicity
- transdermal DMPS
-
Phoenix, ArizonaDepartment of Medical Toxicology
Jun 21, 2011
Porphyria Cutanea Tarda Trial in Colombes (Exjade)
Unknown status
- Porphyria Cutanea Tarda
-
Colombes, Ile de France, FranceHopital Louis Mourier, GI unit,
Jan 26, 2011
Lymphoma, B-Cell Trial in Cleveland (external beam radiotherapy plus 90-Y ibritumomab tiuxetan)
Completed
- Lymphoma, B-Cell
- external beam radiotherapy plus 90-Y ibritumomab tiuxetan
-
Cleveland, OhioCleveland Clinic
Dec 20, 2010
Chemo, Colon Cancer Trial in Jönköping (Mangafodipir, Placebo treatment (0.9% NaCl))
Completed
- Chemotherapy
- Colon Cancer
- Mangafodipir
- Placebo treatment (0.9% NaCl)
-
Jönköping, SwedenOnkologkliniken, Länssjukhuset Ryhov
May 3, 2010
Beta-Thalassemia Trial in Cagliari (deferiprone)
Unknown status
- Beta-Thalassemia
-
Cagliari, Sardinia, ItalyOspedale Microcitemico, Via Jenner
Jun 23, 2005